Tovedeso 7 mg tablete sa produljenim oslobađanjem
| Name | Tovedeso 7 mg tablete sa produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-862475317 |
| Active Substance | desfesoterodinsukcinat |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 7 mg desfesoterodinsukcinata, što odgovara 5,2 mg desfesoterodina |
| Pharmaceutical Form | tableta s produljenim oslobađanjem |
| Manufacturer | Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka Teva Pharma B.V., Haarlem, Nizozemska Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 15.06.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/166 |
| Registration Number | 381-12-01/70-22-02 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | G04BD13 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
